fda warning letter hims compounded semaglutide 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Hims & Hers falls 8%

The changes in biological metabolites (e.g., iron and lipids) support the potential use of ferroptosis, a unique form of cell death, as a therapeutic strategy for RCC

Hydrolyzed Bovine Collagen 3 g Provides 3 g hydrolyzed bovine collagen per serving for daily collagen and connective tissue nutrition

Sclerotherapy Targeted Vein Treatment for Clearer, Smoother Skin Sclerotherapy is a safe and effective injectable treatment used to diminish the appearance of spider veins and small varicose veins by collapsing the targeted blood vessels

Not everyone who uses a GLP-1 will benefit from or be successful with the therapy, so covering GLP-1s across the board is too costly and would mean higher premiums for everyone

Hambidge KM, Miller LV, Westcott JE, Sheng X, Krebs NF